$AVNS
AVANOS MEDICAL, INC. Stock $avns

$avns Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000160649824000018 Filed on February 21, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$166.1M	$173.3M	$673.3M
YoY Change	-13.35%	-20.32%	-17.89%
Cost Of Revenue	$71.30M	$78.30M	$293.6M
YoY Change	-18.23%	-22.17%	-20.65%
Gross Profit	$94.80M	$95.00M	$379.7M
YoY Change	-9.28%	-18.73%	-15.62%
Gross Profit Margin	57.07%	54.82%	56.39%
Selling, General & Admin	$83.60M	$74.50M	$335.0M
YoY Change	-9.82%	-9.37%	-2.02%
% of Gross Profit	88.19%	78.42%	88.23%
Research & Development	$7.000M	$6.800M	$27.20M
YoY Change	-11.39%	-9.33%	-11.11%
% of Gross Profit	7.38%	7.16%	7.16%
Depreciation & Amortization	$11.40M	$11.50M	$46.10M
YoY Change	-5.79%	-14.18%	-3.35%
% of Gross Profit	12.03%	12.11%	12.14%
Operating Expenses	$90.60M	$83.80M	$362.2M
YoY Change	-9.94%	-7.2%	-2.77%
Operating Profit	$4.000M	$11.20M	$4.200M
YoY Change	53.85%	-57.89%	-94.32%
Interest Expense	$3.100M	-$2.300M	$15.00M
YoY Change	-11.43%	0.0%	50.0%
% of Operating Profit	77.5%	-20.54%	357.14%
Other Income/Expense, Net
YoY Change
Pretax Income	$1.500M	$8.900M	-$7.900M
YoY Change	-475.0%	-62.76%	-112.12%
Income Tax	$1.000M	-$2.100M	$2.000M
% Of Pretax Income	66.67%	-23.6%
Net Earnings	-$900.0K	$10.50M	-$61.80M
YoY Change	80.0%	-37.87%	-222.38%
Net Earnings / Revenue	-0.54%	6.06%	-9.18%
Basic Earnings Per Share	-$0.02		-$1.32
Diluted Earnings Per Share	-$0.02	$0.24	-$1.32
COMMON SHARES
Basic Shares Outstanding	46.20M shares	46.43M shares	46.60M shares
Diluted Shares Outstanding	46.70M shares		46.60M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$75.80M	$87.70M	$87.70M
YoY Change	-20.79%	-31.32%	-31.32%
Cash & Equivalents	$75.80M	$87.70M	$87.70M
Short-Term Investments
Other Short-Term Assets	$95.10M	$93.30M	$93.30M
YoY Change	517.53%	571.22%	571.22%
Inventory	$165.6M	$163.2M	$163.2M
Prepaid Expenses
Receivables	$117.2M	$142.8M	$142.8M
Other Receivables	$14.10M	$0.00	$0.00
Total Short-Term Assets	$467.8M	$487.0M	$487.0M
YoY Change	3.09%	-2.56%	-2.56%
LONG-TERM ASSETS
Property, Plant & Equipment	$116.2M	$117.2M	$144.0M
YoY Change	-28.93%	-28.49%	-25.96%
Goodwill	$794.9M	$796.1M
YoY Change	-3.24%	-2.84%
Intangibles	$232.8M	$239.5M
YoY Change	-4.86%	-4.58%
Long-Term Investments
YoY Change
Other Assets	$19.10M	$19.30M	$25.80M
YoY Change	2.69%	9.66%	16.22%
Total Long-Term Assets	$1.194B	$1.205B	$1.205B
YoY Change	-6.84%	-6.35%	-6.35%
TOTAL ASSETS
Total Short-Term Assets	$467.8M	$487.0M	$487.0M
Total Long-Term Assets	$1.194B	$1.205B	$1.205B
Total Assets	$1.661B	$1.692B	$1.692B
YoY Change	-4.24%	-5.29%	-5.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$57.00M	$56.30M	$56.30M
YoY Change	-4.36%	-17.08%	-17.08%
Accrued Expenses	$75.10M	$93.20M	$106.0M
YoY Change	-6.82%	-5.76%	-5.1%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$9.400M	$8.600M	$8.600M
YoY Change	51.61%	38.71%	38.71%
Total Short-Term Liabilities	$205.2M	$234.6M	$234.6M
YoY Change	29.46%	26.26%	26.26%
LONG-TERM LIABILITIES
Long-Term Debt	$167.2M	$159.4M	$159.4M
YoY Change	-18.32%	-29.56%	-29.56%
Other Long-Term Liabilities	$10.80M	$10.00M	$38.30M
YoY Change	-30.32%	-57.45%	-34.19%
Total Long-Term Liabilities	$10.80M	$10.00M	$197.7M
YoY Change	-30.32%	-96.0%	-30.51%
TOTAL LIABILITIES
Total Short-Term Liabilities	$205.2M	$234.6M	$234.6M
Total Long-Term Liabilities	$10.80M	$10.00M	$197.7M
Total Liabilities	$433.4M	$456.1M	$456.1M
YoY Change	-0.64%	-7.99%	-7.99%
SHAREHOLDERS EQUITY
Retained Earnings	-$315.8M	-$314.9M
YoY Change	24.53%	24.42%
Common Stock	$500.0K	$500.0K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.228B	$1.236B	$1.236B
YoY Change
Total Liabilities & Shareholders Equity	$1.661B	$1.692B	$1.692B
YoY Change	-4.24%	-5.29%	-5.29%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$900.0K	$10.50M	-$61.80M
YoY Change	80.0%	-37.87%	-222.38%
Depreciation, Depletion And Amortization	$11.40M	$11.50M	$46.10M
YoY Change	-5.79%	-14.18%	-3.35%
Cash From Operating Activities	-$8.000M	$12.70M	$32.40M
YoY Change	17.65%	-62.31%	-64.36%
INVESTING ACTIVITIES
Capital Expenditures	$4.100M	$5.900M	$17.80M
YoY Change	2.5%	20.41%	-7.77%
Acquisitions			$49.60M
YoY Change			-57.28%
Other Investing Activities	$2.100M	$86.90M	$39.40M
YoY Change			-133.94%
Cash From Investing Activities	-$2.000M	$81.00M	$21.60M
YoY Change	-50.0%	-1753.06%	-115.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$19.10M
YoY Change			-58.02%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$700.0K	-114.7M	-$94.20M
YoY Change	-96.83%	423.74%	-266.14%
NET CHANGE
Cash From Operating Activities	-$8.000M	12.70M	$32.40M
Cash From Investing Activities	-$2.000M	81.00M	$21.60M
Cash From Financing Activities	-$700.0K	-114.7M	-$94.20M
Net Change In Cash	-$11.90M	-21.00M	-$40.00M
YoY Change	-62.81%	-404.35%	-534.78%
FREE CASH FLOW
Cash From Operating Activities	-$8.000M	$12.70M	$32.40M
Capital Expenditures	$4.100M	$5.900M	$17.80M
Free Cash Flow	-$12.10M	$6.800M	$14.60M
YoY Change	12.04%	-76.39%	-79.61%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	us-gaap	Interest Expense InterestExpense	3300000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1236300000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	38300000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	15900000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-39000000.0	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1400000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	223400000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	104800000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	118600000	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001606498
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	avns	Lessee Operating Lease Liability Undiscounted Excess Amount Not Disclosed LesseeOperatingLeaseLiabilityUndiscountedExcessAmountNotDisclosed		usd
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-36440
CY2023	dei	Entity Registrant Name EntityRegistrantName	Avanos Medical, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-4987888
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	5405 Windward Parkway
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100 South
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Alpharetta,
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30004
CY2023	dei	City Area Code CityAreaCode	844
CY2023	dei	Local Phone Number LocalPhoneNumber	428-2667
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	1191714961	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	46202992	shares
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	673300000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	684100000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	587000000.0	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	293600000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	289900000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	287800000	usd
CY2023	us-gaap	Gross Profit GrossProfit	379700000	usd
CY2022	us-gaap	Gross Profit GrossProfit	394200000	usd
CY2021	us-gaap	Gross Profit GrossProfit	299200000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	29200000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	30600000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	285300000	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	2900000	usd
CY2023	us-gaap	Interest Expense InterestExpense	15000000.0	usd
CY2022	us-gaap	Interest Expense InterestExpense	10000000.0	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7900000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	26700000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-42100000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000000.0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5200000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11200000	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-9900000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	21500000	usd
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-30900000	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-51900000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	29000000.0	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	37200000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-61800000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	50500000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	6300000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.21
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.46
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.64
CY2023	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-1.11
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.62
CY2021	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.77
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.32
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.08
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.21
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.46
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.64
CY2023	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-1.11
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0.61
CY2021	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0.77
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.32
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.07
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-61800000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	50500000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	6300000	usd
CY2023	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	300000	usd
CY2022	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-300000	usd
CY2021	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-400000	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	9100000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2300000	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-6100000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	0	usd
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	0	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	8800000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2000000.0	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-5700000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-53000000.0	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	48500000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	600000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	87700000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	127700000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	142800000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	167900000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	163200000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	132300000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	28800000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	13900000	usd
CY2023Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	64500000	usd
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	182300000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	487000000.0	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	624100000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	117200000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	118600000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	26800000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	27500000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	796100000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	760300000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	239500000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	234200000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	6500000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	4600000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	19300000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	17600000	usd
CY2023Q4	us-gaap	Assets Assets	1692400000	usd
CY2022Q4	us-gaap	Assets Assets	1786900000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	8600000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6200000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12800000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12000000.0	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	56300000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	67900000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	93200000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	97800000	usd
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	63700000	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	7100000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	234600000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	191000000.0	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	159400000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	226300000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	28300000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	32500000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	23800000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	25400000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10000000.0	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	20500000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	456100000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	495700000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46174337	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46528907	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	500000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	500000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1663600000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1646400000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-314900000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-253100000	usd
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	85900000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	66800000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-27000000.0	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-35800000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1236300000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1291200000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1692400000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1786900000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	1262100000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	6300000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6200000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13200000	usd
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	11500000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-5700000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1270600000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	50500000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	500000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	15900000	usd
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	44300000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2000000.0	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1291200000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-61800000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-2700000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	15800000	usd
CY2023	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	15000000.0	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	8800000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-61800000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	50500000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	6300000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	46100000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	47700000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	15800000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	13200000	usd
CY2023	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-70800000	usd
CY2022	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2021	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2023	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-1900000	usd
CY2022	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-1100000	usd
CY2021	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-8000000.0	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-11900000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-7100000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	33400000	usd
CY2023	avns	Increase Decreasein Deferred Income Taxesand Other IncreaseDecreaseinDeferredIncomeTaxesandOther	22400000	usd
CY2022	avns	Increase Decreasein Deferred Income Taxesand Other IncreaseDecreaseinDeferredIncomeTaxesandOther	0	usd
CY2021	avns	Increase Decreasein Deferred Income Taxesand Other IncreaseDecreaseinDeferredIncomeTaxesandOther	3000000.0	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	32400000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	90900000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	87300000	usd
CY2023	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	17800000	usd
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	19300000	usd
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	21000000.0	usd
CY2023	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	89000000.0	usd
CY2022	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	usd
CY2021	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	49600000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	116100000	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	21600000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-135400000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21000000.0	usd
CY2023	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	250000000.0	usd
CY2021	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	4700000	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	126600000	usd
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	usd
CY2023	avns	Payments Credits Of Debt Issuance Costs Net PaymentsCreditsOfDebtIssuanceCostsNet	0	usd
CY2022	avns	Payments Credits Of Debt Issuance Costs Net PaymentsCreditsOfDebtIssuanceCostsNet	2900000	usd
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2023	avns	Proceeds From Lines Of Credit Net ProceedsFromLinesOfCreditNet	55000000.0	usd
CY2022	avns	Proceeds From Lines Of Credit Net ProceedsFromLinesOfCreditNet	150000000.0	usd
CY2021	avns	Payments Credits Of Debt Issuance Costs Net PaymentsCreditsOfDebtIssuanceCostsNet	-20000000.0	usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	115000000.0	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	170000000.0	usd
CY2021	avns	Proceeds From Lines Of Credit Net ProceedsFromLinesOfCreditNet	-70000000.0	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	19100000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	45500000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	11500000	usd
CY2023	avns	Proceeds And Excess Tax Benefits From Stock Option Exercises ProceedsAndExcessTaxBenefitsFromStockOptionExercises	1300000	usd
CY2022	avns	Proceeds And Excess Tax Benefits From Stock Option Exercises ProceedsAndExcessTaxBenefitsFromStockOptionExercises	1700000	usd
CY2021	avns	Proceeds And Excess Tax Benefits From Stock Option Exercises ProceedsAndExcessTaxBenefitsFromStockOptionExercises	6200000	usd
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	11700000	usd
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-94200000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	56700000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-55300000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	200000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3000000.0	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-4000000.0	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-40000000.0	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	9200000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7000000.0	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	127700000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	118500000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	111500000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	87700000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	127700000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	118500000	usd
CY2023	avns	Payments Proceeds For Income Taxes PaymentsProceedsForIncomeTaxes	-23600000	usd
CY2022	avns	Payments Proceeds For Income Taxes PaymentsProceedsForIncomeTaxes	2900000	usd
CY2021	avns	Payments Proceeds For Income Taxes PaymentsProceedsForIncomeTaxes	45000000.0	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	14700000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	8100000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	3000000.0	usd
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3400000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3900000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	5600000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of consolidated financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting periods. Estimates are used in accounting for, among other things, certain amounts included in discontinued operations, certain amounts included in assets and liabilities held for sale, distributor rebate accruals, future cash flows associated with impairment testing for goodwill and long-lived assets, loss contingencies, and deferred tax assets and potential income tax assessments. Our estimates are subject to uncertainties associated with the recent COVID-19 pandemic which has caused volatility and adverse effects in global markets. Actual results could differ from these estimates, and the effect of the change could be material to our financial statements. Changes in these estimates are recorded when known.</span></div>
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reportingunit
CY2023	avns	Revenue Performance Obligation Description Of Payment Terms Supply Agreement Term RevenuePerformanceObligationDescriptionOfPaymentTermsSupplyAgreementTerm	P3Y
CY2023	avns	Revenue Performance Obligation Description Of Payment Terms Term RevenuePerformanceObligationDescriptionOfPaymentTermsTerm	P30D
CY2023	avns	Revenue Performance Obligation Description Of Payment Terms Discount Percentage RevenuePerformanceObligationDescriptionOfPaymentTermsDiscountPercentage	0.01
CY2023	avns	Revenue Performance Obligation Description Of Payment Terms Discount Term RevenuePerformanceObligationDescriptionOfPaymentTermsDiscountTerm	P15D
CY2023Q4	avns	Accrued Sales Returns AccruedSalesReturns	100000	usd
CY2022Q4	avns	Accrued Sales Returns AccruedSalesReturns	100000	usd
CY2023Q4	avns	Accrued Rebates AccruedRebates	10400000	usd
CY2022Q4	avns	Accrued Rebates AccruedRebates	14500000	usd
CY2023Q4	avns	Accrued Incentives AccruedIncentives	7300000	usd
CY2022Q4	avns	Accrued Incentives AccruedIncentives	12400000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	700000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1400000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-500000	usd
CY2023Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	33600000	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	14100000	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	12200000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	142800000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	167900000	usd
CY2023	us-gaap	Restructuring Charges RestructuringCharges	28200000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2021	us-gaap	Restructuring Charges RestructuringCharges	22600000	usd
CY2023Q1	avns	Restructuring Plan Term RestructuringPlanTerm	P3Y
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021Q4	us-gaap	Goodwill Goodwill	742500000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	760300000	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	600000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	796100000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	134000000.0	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	162100000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	700000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-500000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	50300000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	36700000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	19800000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	23800000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	88500000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	69800000	usd
CY2023Q4	us-gaap	Other Inventory Supplies OtherInventorySupplies	4600000	usd
CY2022Q4	us-gaap	Other Inventory Supplies OtherInventorySupplies	2000000.0	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	163200000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	132300000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	5100000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	8200000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	9800000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	240100000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	122900000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	117200000	usd
CY2023Q4	us-gaap	Accumulated Capitalized Interest Costs AccumulatedCapitalizedInterestCosts	500000	usd
CY2022Q4	us-gaap	Accumulated Capitalized Interest Costs AccumulatedCapitalizedInterestCosts	100000	usd
CY2023	us-gaap	Depreciation Depreciation	19200000	usd
CY2022	us-gaap	Depreciation Depreciation	17500000	usd
CY2021	us-gaap	Depreciation Depreciation	17000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	498300000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	258800000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	239500000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	468900000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	234700000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	234200000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	24300000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	23600000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14600000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	25500000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	25000000.0	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	24500000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	24300000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	24300000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	115900000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	239500000	usd
CY2023Q4	avns	Accrued Rebates And Incentives AccruedRebatesAndIncentives	17700000	usd
CY2022Q4	avns	Accrued Rebates And Incentives AccruedRebatesAndIncentives	26900000	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	31500000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	34600000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	16700000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	21200000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	27300000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	15100000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	93200000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	97800000	usd
CY2023Q4	avns	Accrued Compensation Benefits AccruedCompensationBenefits	5900000	usd
CY2022Q4	avns	Accrued Compensation Benefits AccruedCompensationBenefits	4800000	usd
CY2023Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	4100000	usd
CY2022Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	15700000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10000000.0	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	20500000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	26800000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	27500000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12800000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12000000.0	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	28300000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	32500000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	41100000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	44500000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y9M18D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y7M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.045
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.040
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	12800000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	13100000	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	300000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	300000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	1500000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	1000000.0	usd
CY2023	us-gaap	Lease Cost LeaseCost	14600000	usd
CY2022	us-gaap	Lease Cost LeaseCost	14400000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	17500000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	16200000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	10400000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3000000.0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	13500000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	9300000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	7700000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	6200000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	5600000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	5900000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	48200000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	168800000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	233400000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	800000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	900000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	8600000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6200000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	159400000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	226300000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	8600000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	8600000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	9400000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	10200000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	140600000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	168800000	usd
CY2023Q4	avns	Debt Repayment Term DebtRepaymentTerm	P5Y
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-17300000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	21600000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-44100000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	9400000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	5100000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	2000000.0	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7900000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	26700000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-42100000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	3700000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	4900000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-15500000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2400000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2400000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-800000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	4000000.0	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1700000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1300000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	10100000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	9000000.0	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-15000000.0	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-4900000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-4000000.0	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3800000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1900000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	600000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-100000	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-1300000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-400000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	100000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-8100000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3800000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3800000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000000.0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5200000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11200000	usd
CY2023	avns	Cares Act Income Tax Expense Benefit CARESActIncomeTaxExpenseBenefit	0	usd
CY2022	avns	Cares Act Income Tax Expense Benefit CARESActIncomeTaxExpenseBenefit	-3800000	usd
CY2021	avns	Cares Act Income Tax Expense Benefit CARESActIncomeTaxExpenseBenefit	-2800000	usd
CY2023Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	33600000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.041
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.081
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.025
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.118
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.022
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.001
CY2023	avns	Effective Income Tax Rate Reconciliation Foreign Tax Credit Carryback EffectiveIncomeTaxRateReconciliationForeignTaxCreditCarryback	0
CY2022	avns	Effective Income Tax Rate Reconciliation Foreign Tax Credit Carryback EffectiveIncomeTaxRateReconciliationForeignTaxCreditCarryback	0
CY2021	avns	Effective Income Tax Rate Reconciliation Foreign Tax Credit Carryback EffectiveIncomeTaxRateReconciliationForeignTaxCreditCarryback	0.048
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.001
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.012
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.028
CY2023	avns	Effective Income Tax Rate Reconciliation Unrecognized Tax Benefits EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits	0
CY2022	avns	Effective Income Tax Rate Reconciliation Unrecognized Tax Benefits EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits	0
CY2021	avns	Effective Income Tax Rate Reconciliation Unrecognized Tax Benefits EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits	0.010
CY2023	avns	Effective Income Tax Rate Reconciliation Capital Loss Carryback EffectiveIncomeTaxRateReconciliationCapitalLossCarryback	0
CY2022	avns	Effective Income Tax Rate Reconciliation Capital Loss Carryback EffectiveIncomeTaxRateReconciliationCapitalLossCarryback	0
CY2021	avns	Effective Income Tax Rate Reconciliation Capital Loss Carryback EffectiveIncomeTaxRateReconciliationCapitalLossCarryback	0.115
CY2023	avns	Effective Income Tax Rate Reconciliation Cares Act EffectiveIncomeTaxRateReconciliationCARESAct	0
CY2022	avns	Effective Income Tax Rate Reconciliation Cares Act EffectiveIncomeTaxRateReconciliationCARESAct	-0.144
CY2021	avns	Effective Income Tax Rate Reconciliation Cares Act EffectiveIncomeTaxRateReconciliationCARESAct	0.067
CY2023	avns	Effective Income Tax Rate Reconciliation Doj Deferred Prosecution Agreement EffectiveIncomeTaxRateReconciliationDOJDeferredProsecutionAgreement	0
CY2022	avns	Effective Income Tax Rate Reconciliation Doj Deferred Prosecution Agreement EffectiveIncomeTaxRateReconciliationDOJDeferredProsecutionAgreement	0
CY2021	avns	Effective Income Tax Rate Reconciliation Doj Deferred Prosecution Agreement EffectiveIncomeTaxRateReconciliationDOJDeferredProsecutionAgreement	-0.066
CY2023	avns	Effective Income Tax Rate Reconciliation Nondeductible Expense Officer Compensation EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensation	-0.212
CY2022	avns	Effective Income Tax Rate Reconciliation Nondeductible Expense Officer Compensation EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensation	0.056
CY2021	avns	Effective Income Tax Rate Reconciliation Nondeductible Expense Officer Compensation EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensation	-0.030
CY2023	avns	Effective Income Tax Rate Reconciliation Research And Development Credit Percent EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentCreditPercent	-0.226
CY2022	avns	Effective Income Tax Rate Reconciliation Research And Development Credit Percent EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentCreditPercent	0.105
CY2021	avns	Effective Income Tax Rate Reconciliation Research And Development Credit Percent EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentCreditPercent	-0.031
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.072
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.041
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.013
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.245
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.022
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.008
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.253
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.195
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.266
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	9800000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	9200000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5200000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5500000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10300000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	18300000	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	18000000.0	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	10700000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	3700000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	3700000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	400000	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-6100000	usd
CY2023	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent	300000	usd
CY2022	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent	-400000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	400000	usd
CY2023Q4	avns	Deferred Tax Asset Operating Lease Obligations DeferredTaxAssetOperatingLeaseObligations	6200000	usd
CY2022Q4	avns	Deferred Tax Asset Operating Lease Obligations DeferredTaxAssetOperatingLeaseObligations	7300000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	4100000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	4200000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	57700000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	59300000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4300000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9000000.0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	53400000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	50300000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	55300000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	56500000	usd
CY2023Q4	avns	Deferred Tax Liability Operating Lease Right Of Use Asset DeferredTaxLiabilityOperatingLeaseRightOfUseAsset	2900000	usd
CY2022Q4	avns	Deferred Tax Liability Operating Lease Right Of Use Asset DeferredTaxLiabilityOperatingLeaseRightOfUseAsset	3500000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	3800000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	2900000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	8500000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	7900000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	200000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	300000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	70700000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	71100000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	17300000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	20800000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-4700000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1900000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	6600000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	6500000	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	6600000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	4700000	usd
CY2022Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	4000000	usd
CY2023	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	900000	usd
CY2022	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	700000	usd
CY2021	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	800000	usd
CY2023Q4	avns	Defined Benefit Plan Expected Future Benefit Payments Next Five Years DefinedBenefitPlanExpectedFutureBenefitPaymentsNextFiveYears	300000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter	500000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-5700000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2000000.0	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	8800000	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	9100000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-2300000	usd
CY2021	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent	-500000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	-100000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	-100000	usd
CY2023	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	300000	usd
CY2022	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-300000	usd
CY2021	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-400000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	8800000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2000000.0	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-5700000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	5100000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1700000	shares
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15800000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15900000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13200000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1106000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	39.11
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	29.32
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	68000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	36.28
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1036000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	39.32
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10M20D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1036000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	39.32
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y10M20D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	1036000	shares
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P3Y10M24D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1036000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	39.32
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1600000	usd
CY2023	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	0	usd
CY2022	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	0	usd
CY2021	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	15000000	usd
CY2021Q3	us-gaap	Loss Contingency Accrual Payments LossContingencyAccrualPayments	22200000	usd
CY2023	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	10000000	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-9900000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	21500000	usd
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-30900000	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-51900000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	29000000.0	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	37200000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-61800000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	50500000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	6300000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46600000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46900000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48100000	shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	400000	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	500000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46600000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47300000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48600000	shares
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.21
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.46
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.64
CY2023	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-1.11
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.62
CY2021	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.77
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.32
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.08
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.21
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.46
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.64
CY2023	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-1.11
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0.61
CY2021	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0.77
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.32
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.07
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2200000	shares
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	673300000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	684100000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	587000000.0	usd
CY2023Q4	avns	Accrued Rebates AccruedRebates	10400000	usd
CY2022Q4	avns	Accrued Rebates AccruedRebates	14500000	usd
CY2023Q4	avns	Accrued Incentives AccruedIncentives	7300000	usd
CY2022Q4	avns	Accrued Incentives AccruedIncentives	12400000	usd
CY2023Q4	avns	Accrued Rebates And Incentives AccruedRebatesAndIncentives	17700000	usd
CY2022Q4	avns	Accrued Rebates And Incentives AccruedRebatesAndIncentives	26900000	usd
CY2023Q4	avns	Accrued Sales Returns AccruedSalesReturns	100000	usd
CY2022Q4	avns	Accrued Sales Returns AccruedSalesReturns	100000	usd
CY2023Q4	avns	Liabilities For Estimated Rebates And Incentives Net LiabilitiesForEstimatedRebatesAndIncentivesNet	17800000	usd
CY2022Q4	avns	Liabilities For Estimated Rebates And Incentives Net LiabilitiesForEstimatedRebatesAndIncentivesNet	27000000.0	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	117200000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	118600000	usd
CY2023Q3	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P1Y
CY2023Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	25000000	usd
CY2023Q3	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	451965	shares
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	451965	shares
CY2023Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	9200000	usd
CY2023Q3	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	20.39
CY2023Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	15800000	usd
CY2023Q4	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	290688	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	742653	shares
CY2023Q4	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	5800000	usd
CY2023Q4	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	19.90
CY2023Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	10000000.0	usd
CY2023	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	168178	shares
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	4100000	usd
CY2023	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2023	dei	Auditor Location AuditorLocation	Atlanta, Georgia
CY2023	dei	Auditor Location AuditorLocation	Atlanta, Georgia
CY2023	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2023	dei	Auditor Firm AuditorFirmId	34

Files In Submission

Name	View Source	Status
0001606498-24-000018-index-headers.html	Edgar Link	pending
0001606498-24-000018-index.html	Edgar Link	pending
0001606498-24-000018.txt	Edgar Link	pending
0001606498-24-000018-xbrl.zip	Edgar Link	pending
avns-20231231.htm	Edgar Link	pending
avns-20231231.xsd	Edgar Link	pending
avns-20231231_g1.jpg	Edgar Link	pending
avns-20231231_g2.jpg	Edgar Link	pending
avns-20231231_cal.xml	Edgar Link	unprocessable
avns-20231231_def.xml	Edgar Link	unprocessable
avns-20231231_lab.xml	Edgar Link	unprocessable
avns-20231231_htm.xml	Edgar Link	completed
avns2023form10kex191.htm	Edgar Link	pending
avns2023form10kex21.htm	Edgar Link	pending
avns2023form10kex23.htm	Edgar Link	pending
avns2023form10kex24.htm	Edgar Link	pending
avns2023form10kex31a.htm	Edgar Link	pending
avns2023form10kex31b.htm	Edgar Link	pending
avns2023form10kex32a.htm	Edgar Link	pending
avns2023form10kex32b.htm	Edgar Link	pending
avns2023form10kex971.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
avns-20231231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AVNS
AVANOS MEDICAL, INC. Stock $avns

2024 Q1 Form 10-K Financial Statement

#000160649824000018 Filed on February 21, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVNS AVANOS MEDICAL, INC. Stock $avns

2024 Q1 Form 10-K Financial Statement

#000160649824000018 Filed on February 21, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVNS
AVANOS MEDICAL, INC. Stock $avns